ClinicalTrials.gov record

Completed No phase listed Observational Accepts healthy volunteers Results available

Noradrenergic Activity and Attention

ClinicalTrials.gov ID: NCT05120713

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05120713. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Influence of Noradrenergic Activity on Attentional Control in Younger and Older Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Older adults demonstrate increased distractibility by task-irrelevant information which contributes to general cognitive impairment. However, it is yet unclear how changes in noradrenergic activity during aging influences attentional control. In the current study, tonic noradrenergic activity will be increased or decreased to investigate its behavioral and neural effects on attentional control.

Study identification

NCT ID: NCT05120713
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: University of Southern California; Other
Enrollment: 140 participants

Conditions and interventions

Conditions

Aging

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 1, 2021 (Actual)
Primary completion: Nov 20, 2023 (Actual)
Completion: Nov 20, 2023 (Actual)
Last update posted: Sep 19, 2024

2021 – 2023

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
USC Leonard Davis School of Gerontology	Los Angeles	California	90089	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05120713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 19, 2024 · Synced Nov 15, 2026